Home
/
Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. (AQST) Technical Analysis
Updated: 2026-03-17 00:40 UTC · Last close: 4.18 (+3.98%)
Aquestive Therapeutics, Inc. (AQST) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
The latest close for Aquestive Therapeutics, Inc. (AQST) came in at 4.18 (+3.98%). The stock is back above its 50-day average but still below the 200-day average, which suggests improving short-term tone within a still-repairing long-term structure. 20-day momentum is notably strong at +14.52%; price remains inside its roughly 52-week range (2.22–7.49); and ATR14 volatility is elevated at roughly 5.56% of price. RSI(14) stands around 51.9, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further. The chart is currently flagging Cup & handle. Near-term structure is defined by support at 3.61 and resistance at 4.30. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Revenue: 67.43M · Net income: -83.78M · EPS (basic): -0.78. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.
Fundamentals Snapshot
Source: sec
Company
Aquestive Therapeutics, Inc.
Note: This is an algorithmic technical snapshot (not financial advice).